Skip to main content
. 2018 Sep 26;7(11):1208–1216. doi: 10.1530/EC-18-0384

Table 4.

Testosterone, sex hormone-binding globulin, free androgen index and hair testosterone at baseline and during treatment with a combined oral contraceptive or placebo.

Baseline P Treatment Pa
COC (n = 97) Placebo (n = 99) COC (n = 76) Placebo (n = 89)
Testosterone (nmol/L) 1.54 (1.22–2.10) 1.53 (1.25–2.00) NS 1.37 (1.04–1.77) 1.67 (1.27–2.15) 0.002
SHBG 72 (47–104) 75 (54–99) NS 103 (74–129) 62 (44–81) 0.000
Free androgen index 2.40 (1.39–4.04) 2.11 (1.39– 3.28) NS 1.44 (0.95–2.08) 2.87 (1.80–4.57) 0.000
(n = 90) (n = 87) (n = 75) (n = 78)
Hair testosterone (pg/mg) 1.33 (1.02–1.92) 1.28 (0.95–1.69) NS 1.26 (1.02–1.74) 1.41 (1.00–1.81) NS

Data displayed as median (IQR).

aSignificant P values have been calculated on delta values treatment – baseline, Mann–Whitney U test.

COC, combined oral contraceptive; NS, not significant; SHBG, sex hormone-binding globulin.